Zhaoke Ophthalmology Limited (HKG:6622)
Hong Kong · Delayed Price · Currency is HKD 2.670
+0.070 (2.69%)
Jul 10, 2026, 11:24 AM HKT
Zhaoke Ophthalmology Revenue
In the year 2025, Zhaoke Ophthalmology had annual revenue of 31.97M CNY, down -53.88%. Zhaoke Ophthalmology had revenue of 16.17M in the half year ending December 31, 2025, with 117.18% growth.
Revenue
31.97M CNY
Revenue Growth
-53.88%
P/S Ratio
40.10
Revenue / Employee
115.85K CNY
Employees
276
Market Cap
1.43B HKD
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 31.97M | -37.35M | -53.88% |
| Dec 31, 2024 | 69.32M | 50.57M | 269.73% |
| Dec 31, 2023 | 18.75M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.45B |
| AIM Vaccine | 1.30B |
| Mabpharm | 718.98M |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 171.70M |
| CANbridge Pharmaceuticals | 55.62M |
| Beijing Biostar Pharmaceuticals | 37.13M |
| SinoMab BioScience | 6.28M |
| Clover Biopharmaceuticals | 3.90M |